1. Home
  2. SON vs BLLN Comparison

SON vs BLLN Comparison

Compare SON & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonoco Products Company

SON

Sonoco Products Company

HOLD

Current Price

$57.14

Market Cap

5.6B

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$89.24

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SON
BLLN
Founded
1899
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
4.6B
IPO Year
2014
2025

Fundamental Metrics

Financial Performance
Metric
SON
BLLN
Price
$57.14
$89.24
Analyst Decision
Buy
Buy
Analyst Count
9
7
Target Price
$60.13
$126.71
AVG Volume (30 Days)
1.1M
779.6K
Earning Date
04-21-2026
05-06-2026
Dividend Yield
4.39%
N/A
EPS Growth
510.30
103.40
EPS
0.68
0.48
Revenue
$7,518,753,000.00
$305,112,000.00
Revenue This Year
$0.10
$46.29
Revenue Next Year
$1.82
$30.14
P/E Ratio
$83.46
$195.65
Revenue Growth
41.72
99.97
52 Week Low
$38.65
$61.96
52 Week High
$60.67
$150.44

Technical Indicators

Market Signals
Indicator
SON
BLLN
Relative Strength Index (RSI) 51.92 33.40
Support Level $55.38 $83.59
Resistance Level $58.08 $99.29
Average True Range (ATR) 1.40 6.68
MACD -0.24 -4.24
Stochastic Oscillator 47.95 1.13

Price Performance

Historical Comparison
SON
BLLN

About SON Sonoco Products Company

Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: